Pheton Ltd Class A Ordinary Shares (PTHL) Revenue & Revenue Breakdown
Pheton Ltd Class A Ordinary Shares Revenue Highlights
Latest Revenue (Y)
$448.20K
Latest Revenue (Q)
$118.85K
Pheton Ltd Class A Ordinary Shares Revenue by Period
Pheton Ltd Class A Ordinary Shares Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $448.20K | -28.70% |
| 2023-12-31 | $628.59K | -7.53% |
| 2022-12-31 | $679.78K | -3.27% |
| 2021-12-31 | $702.78K | - |
Pheton Ltd Class A Ordinary Shares generated $448.20K in revenue during NA 2024, up -28.70% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Pheton Ltd Class A Ordinary Shares Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $118.85K | - |
| 2024-09-30 | $118.85K | 12.93% |
| 2024-06-30 | $105.24K | - |
| 2024-03-31 | $105.24K | -41.82% |
| 2023-12-31 | $180.90K | - |
| 2023-09-30 | $180.90K | 35.61% |
| 2023-06-30 | $133.39K | - |
Pheton Ltd Class A Ordinary Shares generated $118.85K in revenue during Q4 2024, up 0.00% compared to the previous quarter, and up 65.70% compared to the same period a year ago.
Pheton Ltd Class A Ordinary Shares Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PAVM | PAVmed | $3.00B | $5.00M |
| DHAI | DIH US | $62.86M | $19.81M |
| SSKN | STRATA Skin Sciences | $33.56M | $6.93M |
| LFWD | Lifeward | $25.66M | $6.20M |
| BMRA | Biomerica | $5.42M | $1.38M |
| SINT | Sintx | $2.89M | $208.00K |
| XAIR | Beyond Air | $1.16M | $1.82M |
| PTHL | Pheton Ltd Class A Ordinary Shares | $448.20K | $118.85K |
| NEUP | Neuphoria Therapeutics | - | - |
| IINN | Inspira Technologies Oxy B.H.N. | - | - |
| RNAZ | TransCode Therapeutics | - | - |